EUVIMEDEUVIMED entdecken
Crossref

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity

Rahul Kesarwani, Nikita Pal, Dorothy Das, Asis Bala iD, Krishna P Bhabak iD

Journal of Medicinal Chemistry · 23.07.2026 · 69 (14) · 17342-17365

DOI: 10.1021/acs.jmedchem.6c01286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 02.07.2026. Verfasst von Rahul Kesarwani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India. Hauptthemen laut MEDLINE: Prodrugs, Glutathione S-Transferase pi, Antineoplastic Agents, Fluorescent Dyes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Indian Institute of Technology Guwahati, Science and Engineering Research Board, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsGlutathione S-Transferase piAntineoplastic AgentsFluorescent DyesEnzyme InhibitorsHumansAnimalsZebrafishReactive Oxygen SpeciesMDA-MB-231 CellsStructure-Activity RelationshipCell Line, TumorDrug Delivery Systems

Substanzen

ProdrugsGlutathione S-Transferase piAntineoplastic AgentsReactive Oxygen SpeciesFluorescent DyesGSTP1 protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
  • Pharmacology and Drug Discovery Research Laboratory, Division of Life Sciences, Institute of Advanced Study in Science and Technology (IASST), Vigyan Path, Guwahati 781035, Assam, India.

ORCID-Profile: Asis Bala, Krishna P Bhabak

Förderung

  • Indian Institute of Technology Guwahati
  • Science and Engineering Research Board
  • Ministry of Education, India

Zitieren

APA

Kesarwani, R., Pal, N., Das, D., Bala, A., & Bhabak, K. P. (2026). Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity. Journal of Medicinal Chemistry, 69(14), 17342-17365. https://doi.org/10.1021/acs.jmedchem.6c01286

Vancouver

Kesarwani R, Pal N, Das D, Bala A, Bhabak KP. Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity. Journal of Medicinal Chemistry. 2026;69(14):17342-17365. doi:10.1021/acs.jmedchem.6c01286

BibTeX
@article{Kesarwani2026,
  author = {Kesarwani, Rahul and Pal, Nikita and Das, Dorothy and Bala, Asis and Bhabak, Krishna P},
  title = {Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {14},
  pages = {17342--17365},
  doi = {10.1021/acs.jmedchem.6c01286}
}
Kostenlos starten →